Skip to content

Those Who anderblog

Conspicuous Ideas for your Update

Menu
Menu

Valneva Debuts NASDAQ and Competes with Other Biotech Stocks

Posted on May 18, 2021May 18, 2021 by admin

Most of the biotech companies are enjoying soaring stock price in 2021. In this race, Valneva has joined the market. This French vaccine development company is giving tough competition to other companies.

This company have already developed two vaccines that are approved. Currently, they are in the process of developing three other vaccines. Out of these three one vaccine, one is for Covid-19 infection.

Because of this reason, many investors are looking forward to investing in the shares of this company, i.e. NASDAQ VALN at https://www.webull.com/quote/nasdaq-valn.

Previously, it was only listening in Paris. However, with the growing demand, the company have decided to debut NASDAQ by issuing 7.1 million ordinary shares.

Valneva IPO (NASDAQ Listing):

Valneva has become a big name in the biotech and pharma market. However, there was no platform for this company to raise money from US investors. Because of this, they have launched an IPO.

They have issued 7.1 million ordinary shares to investors in America as well as Europe. It is already listed on the Euronext Paris platform. However, now the company have debuted on NASDAQ as well.

The stock is listed as NASDAQ VALN. Now, American, as well as European investors, can easily buy and sell the shares of this company.

In the US, the stocks are available to all investors. However, in Europe, only qualified investors are allowed to purchase the shares. It has been approved for NASDAQ listing and has already listed the shares.

The current value of NASDAQ VALN is $28.86. There is a 3.07% gain for investors. The decision to offer shares and get listed on NASDAQ came when the company was in need of funds.

Funds for Vaccine Development:

The company is going to use the raised funds for vaccine development. They need nearly $100 million for developing a vaccine for Lyme disease.

They need $80 million for development, texting and conducting clinical trials for the Covid-19 vaccine, i.e. VLA2001.

Apart from that, they also need $120 million to develop the Chikungunya vaccine. The name of the vaccine is VLA1553.

The company have made the right decision to issue shares via IPO and raise money. It is a strong move as the competition in the market is increasing day by day.

Competition from Other Biotech Stocks:

NASDAQ VALN is facing competition from many other biotech stocks. Out of all the stocks, the biggest competition is from Ocugen. It is another biotech company which have successful manufactured the Covid-19 vaccine.

Even though Valneva has not yet manufactured the vaccine for covid-19, it is performing better than most of the biotech stocks and companies. Before stock trading, you can check more stocks like nyse cciv ws at https://www.webull.com/quote/nyse-cciv-ws.

Recent Posts

  • Why orthodontic retainers are crucial for maintaining your perfect smile?
  • Mattress buying guide- what to look for and how to make the right choice
  • How to secure the best financing for your used car purchase?
  • Top 5 Bathroom Wall Cabinet Styles to Consider
  • How to Excavate Your Custom Home on a Budget?

Recent Comments

    Archives

    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020

    Categories

    • Auto
    • business
    • Buy delta 8
    • CBD
    • Education
    • Entertainment
    • Fashion
    • Finance
    • Food
    • Games
    • general
    • health
    • Health And Fitness
    • home
    • Home Improvement
    • Law
    • Pets
    • real estate
    • seo
    • Shopping
    • sports
    • Technology
    • Travel

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    ©2023 Those Who anderblog | Built using WordPress and Responsive Blogily theme by Superb